Highlights

[SYMLIFE] YoY Cumulative Quarter Result on 2011-09-30 [#2]

Stock [SYMLIFE]: SYMPHONY LIFE BHD
Announcement Date 24-Nov-2011
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2012
Quarter 30-Sep-2011  [#2]
Profit Trend QoQ -     106.83%    YoY -     100.11%
Quarter Report


View:


Show?  YoY % Horiz. %

Cumulative Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 126,925 197,951 166,565 163,163 116,889 119,858 177,601 -5.44%
  YoY % -35.88% 18.84% 2.09% 39.59% -2.48% -32.51% -
  Horiz. % 71.47% 111.46% 93.79% 91.87% 65.82% 67.49% 100.00%
PBT 39,125 32,108 29,218 25,704 12,070 21,719 30,725 4.11%
  YoY % 21.85% 9.89% 13.67% 112.96% -44.43% -29.31% -
  Horiz. % 127.34% 104.50% 95.10% 83.66% 39.28% 70.69% 100.00%
Tax -6,102 -7,999 -8,098 -9,751 -4,014 -6,664 -9,940 -7.81%
  YoY % 23.72% 1.22% 16.95% -142.92% 39.77% 32.96% -
  Horiz. % 61.39% 80.47% 81.47% 98.10% 40.38% 67.04% 100.00%
NP 33,023 24,109 21,120 15,953 8,056 15,055 20,785 8.02%
  YoY % 36.97% 14.15% 32.39% 98.03% -46.49% -27.57% -
  Horiz. % 158.88% 115.99% 101.61% 76.75% 38.76% 72.43% 100.00%
NP to SH 33,374 24,103 21,578 16,207 8,099 12,010 18,782 10.05%
  YoY % 38.46% 11.70% 33.14% 100.11% -32.56% -36.06% -
  Horiz. % 177.69% 128.33% 114.89% 86.29% 43.12% 63.94% 100.00%
Tax Rate 15.60 % 24.91 % 27.72 % 37.94 % 33.26 % 30.68 % 32.35 % -11.44%
  YoY % -37.37% -10.14% -26.94% 14.07% 8.41% -5.16% -
  Horiz. % 48.22% 77.00% 85.69% 117.28% 102.81% 94.84% 100.00%
Total Cost 93,902 173,842 145,445 147,210 108,833 104,803 156,816 -8.19%
  YoY % -45.98% 19.52% -1.20% 35.26% 3.85% -33.17% -
  Horiz. % 59.88% 110.86% 92.75% 93.87% 69.40% 66.83% 100.00%
Net Worth 595,258 534,726 446,260 433,929 424,103 408,559 415,739 6.16%
  YoY % 11.32% 19.82% 2.84% 2.32% 3.80% -1.73% -
  Horiz. % 143.18% 128.62% 107.34% 104.38% 102.01% 98.27% 100.00%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/12/15 30/09/14 30/12/13 30/09/11 30/09/10 30/12/09 30/09/08 CAGR
Net Worth 595,258 534,726 446,260 433,929 424,103 408,559 415,739 6.16%
  YoY % 11.32% 19.82% 2.84% 2.32% 3.80% -1.73% -
  Horiz. % 143.18% 128.62% 107.34% 104.38% 102.01% 98.27% 100.00%
NOSH 282,113 268,706 262,506 261,403 273,614 274,200 294,850 -0.73%
  YoY % 4.99% 2.36% 0.42% -4.46% -0.21% -7.00% -
  Horiz. % 95.68% 91.13% 89.03% 88.66% 92.80% 93.00% 100.00%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 26.02 % 12.18 % 12.68 % 9.78 % 6.89 % 12.56 % 11.70 % 14.24%
  YoY % 113.63% -3.94% 29.65% 41.94% -45.14% 7.35% -
  Horiz. % 222.39% 104.10% 108.38% 83.59% 58.89% 107.35% 100.00%
ROE 5.61 % 4.51 % 4.84 % 3.73 % 1.91 % 2.94 % 4.52 % 3.66%
  YoY % 24.39% -6.82% 29.76% 95.29% -35.03% -34.96% -
  Horiz. % 124.12% 99.78% 107.08% 82.52% 42.26% 65.04% 100.00%
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 44.99 73.67 63.45 62.42 42.72 43.71 60.23 -4.74%
  YoY % -38.93% 16.11% 1.65% 46.11% -2.26% -27.43% -
  Horiz. % 74.70% 122.31% 105.35% 103.64% 70.93% 72.57% 100.00%
EPS 11.83 8.97 8.22 6.20 2.96 4.38 6.37 10.86%
  YoY % 31.88% 9.12% 32.58% 109.46% -32.42% -31.24% -
  Horiz. % 185.71% 140.82% 129.04% 97.33% 46.47% 68.76% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 2.1100 1.9900 1.7000 1.6600 1.5500 1.4900 1.4100 6.95%
  YoY % 6.03% 17.06% 2.41% 7.10% 4.03% 5.67% -
  Horiz. % 149.65% 141.13% 120.57% 117.73% 109.93% 105.67% 100.00%
Adjusted Per Share Value based on latest NOSH - 631,804
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 20.09 31.33 26.36 25.82 18.50 18.97 28.11 -5.44%
  YoY % -35.88% 18.85% 2.09% 39.57% -2.48% -32.52% -
  Horiz. % 71.47% 111.46% 93.77% 91.85% 65.81% 67.48% 100.00%
EPS 5.28 3.81 3.42 2.57 1.28 1.90 2.97 10.06%
  YoY % 38.58% 11.40% 33.07% 100.78% -32.63% -36.03% -
  Horiz. % 177.78% 128.28% 115.15% 86.53% 43.10% 63.97% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.9422 0.8463 0.7063 0.6868 0.6713 0.6467 0.6580 6.16%
  YoY % 11.33% 19.82% 2.84% 2.31% 3.80% -1.72% -
  Horiz. % 143.19% 128.62% 107.34% 104.38% 102.02% 98.28% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 1.0700 1.1800 0.8000 0.7200 0.9700 0.6400 0.7200 -
P/RPS 2.38 1.60 1.26 1.15 2.27 1.46 1.20 12.08%
  YoY % 48.75% 26.98% 9.57% -49.34% 55.48% 21.67% -
  Horiz. % 198.33% 133.33% 105.00% 95.83% 189.17% 121.67% 100.00%
P/EPS 9.04 13.15 9.73 11.61 32.77 14.61 11.30 -3.65%
  YoY % -31.25% 35.15% -16.19% -64.57% 124.30% 29.29% -
  Horiz. % 80.00% 116.37% 86.11% 102.74% 290.00% 129.29% 100.00%
EY 11.06 7.60 10.28 8.61 3.05 6.84 8.85 3.78%
  YoY % 45.53% -26.07% 19.40% 182.30% -55.41% -22.71% -
  Horiz. % 124.97% 85.88% 116.16% 97.29% 34.46% 77.29% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.51 0.59 0.47 0.43 0.63 0.43 0.51 -
  YoY % -13.56% 25.53% 9.30% -31.75% 46.51% -15.69% -
  Horiz. % 100.00% 115.69% 92.16% 84.31% 123.53% 84.31% 100.00%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 27/11/14 27/11/13 19/11/12 24/11/11 23/11/10 12/11/09 27/11/08 -
Price 0.9700 1.1400 0.8100 0.7300 0.9700 0.6300 0.7200 -
P/RPS 2.16 1.55 1.28 1.17 2.27 1.44 1.20 10.29%
  YoY % 39.35% 21.09% 9.40% -48.46% 57.64% 20.00% -
  Horiz. % 180.00% 129.17% 106.67% 97.50% 189.17% 120.00% 100.00%
P/EPS 8.20 12.71 9.85 11.77 32.77 14.38 11.30 -5.20%
  YoY % -35.48% 29.04% -16.31% -64.08% 127.89% 27.26% -
  Horiz. % 72.57% 112.48% 87.17% 104.16% 290.00% 127.26% 100.00%
EY 12.20 7.87 10.15 8.49 3.05 6.95 8.85 5.49%
  YoY % 55.02% -22.46% 19.55% 178.36% -56.12% -21.47% -
  Horiz. % 137.85% 88.93% 114.69% 95.93% 34.46% 78.53% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.46 0.57 0.48 0.44 0.63 0.42 0.51 -1.70%
  YoY % -19.30% 18.75% 9.09% -30.16% 50.00% -17.65% -
  Horiz. % 90.20% 111.76% 94.12% 86.27% 123.53% 82.35% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS